INDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors.

Ada GirnitaCynthia FournierPeter BjerringSampsa KauppiAnneke AndriessenCharles LyndeMaxwell SauderAndreas Stensvold

Published in: Journal of drugs in dermatology : JDD (2024)

CirAEs are the most common side effects induced by ICIs and may lead to cancer treatment interruption or even discontinuation. Patient education on the prevention of cirAEs using a skincare regimen and treatment recommendations given in the NECOM 4 algorithm may help prevent and manage cirAEs and improve the QoL and outcome of patients receiving ICIs. J Drugs Dermatol. 2024;23:8(Suppl 2):s4-10.

Keyphrases

machine learning
deep learning
healthcare
case report
young adults
neural network
quality improvement
drug induced
replacement therapy